Search for Clinical Trial Results

Sponsored By

Hemoglobinuria - 40 Studies Found

Status Study
Active, not recruiting Study Name: Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
Condition: Paroxysmal Nocturnal Hemoglobinuria
Date: 2011-04-15
Completed Study Name: Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria
Condition: Paroxysmal Hemoglobinuria, Nocturnal
Date: 2005-08-11
Interventions: Drug: Eculizumab
Completed Study Name: Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria
Condition: Paroxysmal Hemoglobinuria
Date: 2002-06-14
Completed Study Name: E07-001: Safety and Efficacy Extension Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients
Condition: Paroxysmal Nocturnal Hemoglobinuria
Date: 2010-08-30
Interventions: Drug: Eculizumab Each vial contains 30 mL of 10 mg/mL eculizumab; dose of 900 mg intravenous every 14 da
Recruiting Study Name: A Treatment Study of ACH-0144471 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Date: 2017-02-01
Interventions: Drug: ACH-0144471 ACH-0144471 will be administered to all patients enrolled in the study.
Completed Study Name: C07-001: Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients
Condition: Paroxysmal Nocturnal Hemoglobinuria
Date: 2010-08-30
Interventions: Biological: Eculizumab Subjects were treated with open label Eculizumab and following the dose described
Active, not recruiting Study Name: An Open-Label, Intrapatient, Dose-Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria
Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Date: 2015-11-02
Interventions:
  • Biological: Study Drug - ALXN1210

Recruiting Study Name: Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of RO7112689 in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria
Condition: Paroxysmal Hemoglobinuria, Nocturnal
Date: 2016-11-01
Interventions:
  • Drug: RO7112689 RO7112689 will
Recruiting Study Name: Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH)
Condition: Paroxysmal Nocturnal Haemoglobinuria (PNH)
Date: 2015-09-10
Interventions: Drug: Coversin Patients enrolled in this protocol will initially be treated with an ablating dose of Cov
Recruiting Study Name: Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria
Condition: Paroxysmal Nocturnal Hemoglobinuria PNH
Date: 2015-08-07
Interventions: Biological: LFG316 LFG316 will be administered to all patients enrolled in the study
Next >>>